Contrary to the findings of previous studies, 800 mg/d of DHA delivered via fish oil capsules does not lower levels of postpartum depression in mothers or improve cognitive or language development in their offspring during early childhood, according to one trial.
Contrary to the findings of previous studies, 800 mg/d of docosahexaenoic acid (DHA) delivered via fish oil capsules does not lower levels of postpartum depression in mothers or improve cognitive or language development in their offspring during early childhood, according to a double-blind, randomized trial from Australia.
The study involved more than 2,000 women with singleton pregnancies of less than 21 weeks' gestation.
Researchers found that the percentage of women with high levels of depressive symptoms during the first 6 months postpartum did not differ between the group of women who took the DHA-filled capsules versus the group who took vegetable oil capsules without DHA (9.67% vs 11.19%; adjusted relative risk [RR], 0.85; 95% CI, 0.70-1.02; P=.09).
Makrides M, Gibson RA, McPhee AJ, et al; DOMInO Investigative Team. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010;304(15):1675-1683.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More